>
Switch to:

BridgeBio Pharma Accounts Payable

: $9.84 Mil (As of Sep. 2020)
View and export this data going back to 2019. Start your Free Trial

BridgeBio Pharma's Accounts Payable for the quarter that ended in Sep. 2020 was $9.84 Mil.

BridgeBio Pharma's quarterly Accounts Payable declined from Mar. 2020 ($13.09 Mil) to Jun. 2020 ($12.84 Mil) and declined from Jun. 2020 ($12.84 Mil) to Sep. 2020 ($9.84 Mil).

BridgeBio Pharma's annual Accounts Payable increased from Dec. 2017 ($1.89 Mil) to Dec. 2018 ($13.51 Mil) but then declined from Dec. 2018 ($13.51 Mil) to Dec. 2019 ($8.85 Mil).


BridgeBio Pharma Accounts Payable Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

BridgeBio Pharma Annual Data
Dec17 Dec18 Dec19
Accounts Payable 1.89 13.51 8.85

BridgeBio Pharma Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Accounts Payable Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.27 8.85 13.09 12.84 9.84

BridgeBio Pharma Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


BridgeBio Pharma Accounts Payable Related Terms


BridgeBio Pharma Accounts Payable Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)